#1063 Poster Board Number.601 (March 25, 9:00-12:30)
Profiling of Compound-Induced Modulation of ERalpha-Coregulator Interaction As a Means to Compare Bisphenol A Analogs. R. Houtman1, R. van Beuningen1, N. Bastiaensen1, T. Khuc2, B. Goodwin2, C. T. Teng3, and R. R. Tice3. 1PamGene International BV, Den Bosch, Netherlands; 2NCAT, NIH, Rockville, MD; and 3DNTP, NIEHS, Research Triangle Park, NC.
Thalidomide Increases Cytochrome P450 Activity and Drug Metabolism in Liver through Direct Activation of Nuclear Receptor CAR and PXR. R. van Beuningen1, N. Murayama2, D. Melchers1, H. Suemizu3, C. Guillouzo4, N. Shibata5, K. Yajima2, M. Utoh2, M. Shimizu2, C. Chesne4, M. Nakamura3, R. Houtman1, and H. Yamazaki2. 1PamGene International BV, Den Bosch, Netherlands; 2Showa Pharmaceutical University, Machida, Japan; 3Central Institute for Experimental Animals, Kawasaki, Japan; 4Biopredic International, Rennes, France; and 5Nagoya Institute of Technology, Nagoya, Japan.
Profiling of Compound-Induced Modulation of CAR-Coregulator Interactions As a Means to Differentiate between Direct and Indirect CAR Activation. J. P. Groten1, D. Melchers1, R. Van Beuningen1, B. Chorley2, J. Corton2, and R. Houtman1. 1PamGene International BV, Den Bosch, Netherlands; and 2EPA, Research Triangle Park, NC.
|R. Van Beuningen
VP Business Development
|PamGene's Other Nuclear Receptor Posters: Information and links for Direct Download|
|PamGene's Keystone 2014 Poster|
|PamGene's EMBO 2013 Poster|
|PamGene's SOT 2013 Poster|